Global mRNA Cancer Vaccines And Therapeutics Market Report 2024

mRNA Cancer Vaccines And Therapeutics Global Market Report 2024 – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Infectious Disease, Cancer, Other Applications), By End User (Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

mRNA Cancer Vaccines And Therapeutics Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : August 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global mRNA Cancer Vaccines And Therapeutics Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

mRNA Cancer Vaccines And Therapeutics Market Definition

mRNA cancer vaccines and therapeutics refer to a type of medical treatment that utilizes messenger RNA (mRNA) to stimulate the immune system to recognize and fight cancer cells. It is used to deliver instructions to cells to produce therapeutic proteins or enzymes and help prime the immune system to identify and destroy cancer cells that express these antigens.

The main mRNA cancer vaccines and therapeutics types are adeno carcinomas, mucinous carcinomas, and adenosquamous carcinomas. Adeno carcinomas refers to a type of cancer that forms in mucus-secreting glands throughout the body. It is applied for infectious disease, cancer, and others and it is used by several end users such as hospitals and clinics, ambulatory surgical centers, research institutes, and others.

mRNA Cancer Vaccines And Therapeutics Market Segmentation

The mRNA cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas

2) By Application: Infectious Disease, Cancer, Other Applications

3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Global mRNA Cancer Vaccines And Therapeutics Market Size 2023 to 2028: Graph

mRNA Cancer Vaccines And Therapeutics Market Size 2024 And Growth Rate

The mRNA cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $52.85 billion in 2023 to $61.52 billion in 2024 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to the shifting lifestyles, the funding support, the favorable regulatory environment, the well-established healthcare infrastructure, and increasing pipeline development.

mRNA Cancer Vaccines And Therapeutics Market Growth Forecast

The mRNA cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $113.41 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to promising clinical trial results, growing awareness and acceptance of mRNA technology, unmet medical needs in cancer treatment, potential for improved patient outcomes and potential for off-the-shelf availability. Major trends in the forecast period include expansion into new therapeutic areas, personalized medicine approach, advancements in mRNA delivery systems, multivalent mRNA Vaccines and artificial intelligence and machine learning in mRNA design.

mRNA Cancer Vaccines And Therapeutics Market Driver: Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth

The rise in the prevalence of cancer is expected to propel the growth of the mRNA cancer vaccine and therapeutic market going forward. Cancer is a broad term for a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, that invade and destroy normal body tissue. The rise in the prevalence of cancer is due to sedentary lifestyles, unhealthy eating habits, and exposure to environmental toxins. mRNA cancer vaccines and therapeutics are required for cancer because they offer personalized, targeted treatments that can enhance the immune system's ability to recognize and attack cancer cells, improving treatment efficacy and patient outcomes. For instance, in January 2023, according to the data published by the American Cancer Society, a US-based non-profit organization working to eliminate cancer, the estimated number of new cancer cases in the United States, was around 1,918,030 in 2022, which increased to 1,958,310 in 2023. Breast cancer is the leading chronic condition in the United States, increasing from 287,850 cases in 2022 to 297,790 cases in 2023, respectively. Therefore, the rise in the prevalence of cancer is driving the growth of the mRNA cancer vaccine and therapeutics market.

Global mRNA Cancer Vaccines And Therapeutics Market Major Players

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

Global mRNA Cancer Vaccines And Therapeutics Market Trend: FDA Approves WGc-043, Boosting Innovations In mRNA Cancer Vaccines And Therapies

Major players operating in the mRNA cancer vaccine and therapeutics market are focused on the development of innovative treatments such as mRNA cancer vaccines to enhance efficacy, improve patient outcomes, and address the growing demand for effective cancer therapies. mRNA cancer vaccines are a type of immunotherapy that use messenger RNA to instruct cells to produce specific antigens, thereby stimulating the immune system to recognize and attack cancer cells. For instance, in May 2024, WestGene Biopharma, a China-based, biotechnology company received FDA approval for an investigational new drug application of its mRNA therapeutic cancer vaccine, WGc-043. The FDA approval of WGc-043 marks a breakthrough in treating advanced EB virus-related cancers, which are strongly linked to over ten malignancies, including nasopharyngeal carcinoma, NK T-cell lymphoma, and gastric, lung, liver, esophageal, breast, and cervical cancers, as well as autoimmune diseases such as multiple sclerosis and lupus.

mRNA Cancer Vaccines And Therapeutics Market Merger And Acquisition: Sanofi Acquires Translate Bio To Enhance mRNA Vaccine And Therapy Development

In September 2021, Sanofi Inc., a France-based pharmaceutical company, completed the acquisition of Translate Bio Inc., for an amount of $3.2 billion. The acquisition enables Sanofi to accelerate its initiatives in developing innovative vaccines and therapies utilizing mRNA technology. The acquisition also bolsters Sanofi's mRNA Center of Excellence, boosting its capacity to investigate advanced mRNA vaccines and other critical areas like immunology, oncology, and rare diseases. Translate Bio Inc. is a US-based, mRNA therapeutics company focusing on mRNA-based medicine development.

Regional Insights For The Global mRNA Cancer Vaccines And Therapeutics Market

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mRNA cancer vaccines and therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

mRNA cancer vaccines and therapeutics market consists of sales of individualized cancer treatment mRNA vaccine, infectious disease treatment mRNA vaccine, and infection prevention mRNA vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The mRNA market research report is one of a series of new reports from The Business Research Company that provides mRNA market statistics, including mRNA industry global market size, regional shares, competitors with a mRNA market share, detailed mRNA market segments, market trends and opportunities, and any further data you may need to thrive in the mRNA industry. This mRNA market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

mRNA Cancer Vaccines And Therapeutics Market Report Forecast and Analysis
Report AttributeDetails
Market Size Value In 2024 $61.52 billion
Revenue Forecast In 2033 $113.41 billion
Growth Rate CAGR of 16.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. mRNA Cancer Vaccines And Therapeutics Market Characteristics

    3. mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies

    4. mRNA Cancer Vaccines And Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global mRNA Cancer Vaccines And Therapeutics Market Size and Growth

    5.1. Global mRNA Cancer Vaccines And Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global mRNA Cancer Vaccines And Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global mRNA Cancer Vaccines And Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. mRNA Cancer Vaccines And Therapeutics Market Segmentation

    6.1. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Adeno Carcinomas

    Mucinous Carcinomas

    Adenosquamous Carcinomas

    6.2. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Infectious Disease

    Cancer

    Other Applications

    6.3. Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Clinics

    Ambulatory Surgical Centers

    Research Institutes

    Other End Users

    7. mRNA Cancer Vaccines And Therapeutics Market Regional And Country Analysis

    7.1. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market

    8.1. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China mRNA Cancer Vaccines And Therapeutics Market

    9.1. China mRNA Cancer Vaccines And Therapeutics Market Overview

    9.2. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India mRNA Cancer Vaccines And Therapeutics Market

    10.1. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan mRNA Cancer Vaccines And Therapeutics Market

    11.1. Japan mRNA Cancer Vaccines And Therapeutics Market Overview

    11.2. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia mRNA Cancer Vaccines And Therapeutics Market

    12.1. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia mRNA Cancer Vaccines And Therapeutics Market

    13.1. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea mRNA Cancer Vaccines And Therapeutics Market

    14.1. South Korea mRNA Cancer Vaccines And Therapeutics Market Overview

    14.2. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe mRNA Cancer Vaccines And Therapeutics Market

    15.1. Western Europe mRNA Cancer Vaccines And Therapeutics Market Overview

    15.2. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK mRNA Cancer Vaccines And Therapeutics Market

    16.1. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany mRNA Cancer Vaccines And Therapeutics Market

    17.1. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France mRNA Cancer Vaccines And Therapeutics Market

    18.1. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy mRNA Cancer Vaccines And Therapeutics Market

    19.1. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain mRNA Cancer Vaccines And Therapeutics Market

    20.1. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market

    21.1. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market Overview

    21.2. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia mRNA Cancer Vaccines And Therapeutics Market

    22.1. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America mRNA Cancer Vaccines And Therapeutics Market

    23.1. North America mRNA Cancer Vaccines And Therapeutics Market Overview

    23.2. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA mRNA Cancer Vaccines And Therapeutics Market

    24.1. USA mRNA Cancer Vaccines And Therapeutics Market Overview

    24.2. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada mRNA Cancer Vaccines And Therapeutics Market

    25.1. Canada mRNA Cancer Vaccines And Therapeutics Market Overview

    25.2. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America mRNA Cancer Vaccines And Therapeutics Market

    26.1. South America mRNA Cancer Vaccines And Therapeutics Market Overview

    26.2. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil mRNA Cancer Vaccines And Therapeutics Market

    27.1. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East mRNA Cancer Vaccines And Therapeutics Market

    28.1. Middle East mRNA Cancer Vaccines And Therapeutics Market Overview

    28.2. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa mRNA Cancer Vaccines And Therapeutics Market

    29.1. Africa mRNA Cancer Vaccines And Therapeutics Market Overview

    29.2. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape And Company Profiles

    30.1. mRNA Cancer Vaccines And Therapeutics Market Competitive Landscape

    30.2. mRNA Cancer Vaccines And Therapeutics Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bayer AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Novartis SA

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. mRNA Cancer Vaccines And Therapeutics Market Other Major And Innovative Companies

    31.1. AstraZeneca Plc

    31.2. GlaxoSmithKline Plc

    31.3. Hoffmann-La Roche AG

    31.4. Eli Lilly and Company

    31.5. Moderna Therapeutics Inc.

    31.6. BioNTech SE

    31.7. Regeneron Pharmaceuticals Inc.

    31.8. Catalent Inc.

    31.9. Sarepta Therapeutics Inc.

    31.10. Arcturus Therapeutics Holdings Inc.

    31.11. Genentech Inc.

    31.12. Immatics Biotechnologies GmbH

    31.13. CureVac N.V

    31.14. Anima Biotech

    31.15. Argos Therapeutics Inc.

    32. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking

    33. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market

    35. mRNA Cancer Vaccines And Therapeutics Market Future Outlook and Potential Analysis

    35.1 mRNA Cancer Vaccines And Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 mRNA Cancer Vaccines And Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 mRNA Cancer Vaccines And Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Merck & Co Inc. Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Novartis SA Financial Performance
  • Table 78: Sanofi AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global mRNA Cancer Vaccines And Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, mRNA Cancer Vaccines And Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Merck & Co Inc. Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Novartis SA Financial Performance
  • Figure 78: Sanofi AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the mRNA cancer vaccines and therapeutics market?

mRNA cancer vaccines and therapeutics refer to a type of medical treatment that utilizes messenger RNA (mRNA) to stimulate the immune system to recognize and fight cancer cells. It is used to deliver instructions to cells to produce therapeutic proteins or enzymes and help prime the immune system to identify and destroy cancer cells that express these antigens. For further insights on the mRNA cancer vaccines and therapeutics market, request a sample here

How will the mRNA cancer vaccines and therapeutics market drivers and restraints affect the mRNA cancer vaccines and therapeutics market dynamics? What forces will shape the mRNA cancer vaccines and therapeutics industry going forward?

The mRNA cancer vaccines and therapeutics market major growth driver - Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth. For further insights on the mRNA cancer vaccines and therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the mRNA cancer vaccines and therapeutics market?

The mRNA cancer vaccines and therapeutics market size has grown rapidly in recent years. It will grow from $52.85 billion in 2023 to $61.52 billion in 2024 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to the shifting lifestyles, the funding support, the favorable regulatory environment, the well-established healthcare infrastructure, and increasing pipeline development. The mRNA cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $113.41 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to promising clinical trial results, growing awareness and acceptance of mRNA technology, unmet medical needs in cancer treatment, potential for improved patient outcomes and potential for off-the-shelf availability. Major trends in the forecast period include expansion into new therapeutic areas, personalized medicine approach, advancements in mRNA delivery systems, multivalent mRNA Vaccines and artificial intelligence and machine learning in mRNA design. For further insights on the mRNA cancer vaccines and therapeutics market, request a sample here

How is the mRNA cancer vaccines and therapeutics market segmented?

The mRNA cancer vaccines and therapeutics market is segmented
1) By Type : Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End UsersFor further insights on the mRNA cancer vaccines and therapeutics market,
request a sample here

Which region has the largest share of the mRNA cancer vaccines and therapeutics market? What are the other regions covered in the report?

North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the mRNA cancer vaccines and therapeutics market, request a sample here.

Who are the major players in the mRNA cancer vaccines and therapeutics market?

Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc. For further insights on the mRNA cancer vaccines and therapeutics market, request a sample here.

What are the key trends in the mRNA cancer vaccines and therapeutics market?

Major trend in the mRNA cancer vaccines and therapeutics market - FDA Approves WGc-043, Boosting Innovations In mRNA Cancer Vaccines And Therapies. For further insights on the mRNA cancer vaccines and therapeutics market, request a sample here.

What are the major opportunities in the mRNA cancer vaccines and therapeutics market? What are the strategies for the mRNA cancer vaccines and therapeutics market?

For detailed insights on the major opportunities and strategies in the mRNA cancer vaccines and therapeutics market, request a sample here.

How does the mRNA cancer vaccines and therapeutics market relate to the overall economy and other similar markets?

For detailed insights on mRNA cancer vaccines and therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the mRNA cancer vaccines and therapeutics industry?

For detailed insights on the mergers and acquisitions in the mRNA cancer vaccines and therapeutics industry, request a sample here.

What are the key dynamics influencing the mRNA cancer vaccines and therapeutics market growth? SWOT analysis of the mRNA cancer vaccines and therapeutics market.

For detailed insights on the key dynamics influencing the mRNA cancer vaccines and therapeutics market growth and SWOT analysis of the mRNA cancer vaccines and therapeutics industry, request a sample here.